VigiLanz Becomes First Clinical Intelligence Platform to Integrate Sanford Guide Infectious Disease Content
MINNEAPOLIS, MN and SPERRYVILLE, VA — (Marketwired) — 09/26/17 — , a digital healthcare intelligence firm, and Antimicrobial Therapy Inc., publisher and developer of The Sanford Guide, announced today an exclusive partnership that brings together the market-leading clinical intelligence platform and the industry–s top digital infectious disease content. Doing so provides VigiLanz users with the critical next step in the clinical surveillance process — access to peer-reviewed recommendation